Centogene N.V. (CNTGF)
OTCMKTS · Delayed Price · Currency is USD
0.0630
+0.0070 (12.50%)
Aug 1, 2025, 4:00 PM EDT
Bally's Market Cap
Centogene has a market cap or net worth of $1.89 million as of August 1, 2025. Its market cap has decreased by -87.81% in one year.
Market Cap
1.89M
Enterprise Value
69.58M
Revenue
53.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since November 5, 2019, Centogene's market cap has decreased from 3.22M to 1.89M, a decrease of -41.38%. That is a compound annual growth rate of -8.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.89M | -52.00% |
| Dec 31, 2024 | 3.93M | -88.24% |
| Dec 29, 2023 | 33.44M | 32.77% |
| Dec 30, 2022 | 25.19M | -78.60% |
| Dec 31, 2021 | 117.70M | -50.06% |
| Dec 31, 2020 | 235.67M | 17.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |